Showing results (311-320 of 475) with videos related to
Sort By:
Pageof 48
Journal of Invertebrate Pathology|June 7, 2011
Genetic and electron-microscopic characterization of Rickettsiella bacteria from the manuka beetle, Pyronota setosa (Coleoptera: Scarabaeidae)Regina G Kleespies, Sean D G Marshall, Christina Schuster, et al.Journal of Applied Research in Intellectual Disabilities : JARID|January 12, 2026
Quality Considerations When Planning and Conducting a Virtual World Café Using an Inclusive Research ApproachLindsay F Rentschler, Ashley Taconet, Brad Linnenkamp, et al.Frontiers in Plant Science|September 13, 2016
Dispersal of the Invasive Pasture Pest Heteronychus arator into Areas of Low Population Density: Effects of Sex and Season, and Implications for Pest ManagementSarah Mansfield, Philippa J Gerard, Mark R H Hurst, et al.Journal of Neuroimmunology|July 17, 1999
Contrasting effects of anti-adhesion molecule therapy in experimental allergic encephalomyelitis and Theiler's murine encephalomyelitisJ W Rose, C T Welsh, K E Hill, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|June 3, 1999
Symposium overview: Characterization of xenobiotic metabolizing enzyme function using heterologous expression systemsA J Townsend, K K Kiningham, D St Clair, et al.Neurosurgery|December 1, 1991
Neurenteric cysts of the posterior fossa: recognition, management, and embryogenesisC P Harris, M S Dias, D L Brockmeyer, et al.The Journal of Biological Chemistry|January 9, 1999
Regulation of MCL1 through a serum response factor/Elk-1-mediated mechanism links expression of a viability-promoting member of the BCL2 family to the induction of hematopoietic cell differentiationK J Townsend, P Zhou, L Qian, et al.Journal of Internal Medicine|July 16, 2003
A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessationP Tønnesen, S Tonstad, A Hjalmarson, et al.Early Human Development|October 20, 2001
Neurodevelopmental status at 1 year predicts neuropsychiatric outcome at 14-15 years of age in very preterm infantsS Roth, J Wyatt, J Baudin, et al.Journal of Neuro-Oncology|February 1, 1993
Phase II evaluation of echinomycin (NSC-526417) in patients with central nervous system malignancies. A Southwest Oncology Group studyS A Taylor, J Crowley, J Townsend, et al.Pageof 48